Skip to main content
OpenTrials
Completed

NCT Number: NCT01947270

Multidisciplinary Program "Optimization of Drug Prescription" : Impact on the Quality of Drug Prescription in Hospitalized Elderly Patients

Drug prescription is a fundamental component of care for the elderly. Even if drugs are a chance for the older patient, because of changes in pharmacological, pharmacokinetic and pharmacodynamic parameters related with age and acute/or chronic pathologies, the risks associated with drug prescription, particularly those associated with potentially inappropriate medication (PIM), are increased in the elderly.

We suppose that many of hospitalized elderly have at least one prescribed medication without valid indication. Conversely, many diseases are currently undertreated in elderly patients: e.g. medicines used to treat heart failure and osteoporosis are underused in 20 to 70% of patients. Moreover, PMI prescription is associated with an increased of morbidity, mortality, risk of drug-related adverse events, utilization of health care system, care costs and impairment of quality of life. Thus, optimization of drug prescription is a major concern for improvement of the quality and safety of care in elderly.

The investigators' hypothesis is that a multidisciplinary program entitled "Optimisation de la Prescription MEDicamenteuse" ("Optimization of drug prescribing") focused on drug prescription optimization including a physician training to the specificity of the drug prescription in the elderly and a checklist allowing an adapted and standardized pharmaceutical analysis is effective in reducing PIM in elderly patients hospitalized in short-term medical and geriatric care departments.

Completed

Looking for future studies?

Notify Me

Key information

Age range

75 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hospices Civils de Lyon - Hôpital Edouard Herriot

Lyon, 69003, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female subject aged over 75 years hospitalized in one of the participating department
  • Patient agreed to participate

Exclusion criteria

  • Patient with a predictive length of stay equal or less than 48 hours
  • Patients admitted in terminal illness

Treatment and study plan

" Optimisation de la Prescription MEDicamenteuse " ("Optimization of drug prescribing")

Other

The multidisciplinary intervention program include:

  • Awareness and training of doctors by two experts (a geriatrician and a pharmacist) within participating departments.
  • Implementation of a checklist which aims to conduct an adapted and standardized pharmaceutical analysis

Primary outcomes

  1. Proportion of potentially inappropriate medications (PIM) prescribed in discharge of hospitalized patients from 75 years old.

    Time frame: at discharge (average 3 weeks)

    Proportion of prescribed PIM will be expressed as the ratio of PIM to the total number of medication in discharge prescription sheet.

    PIM will be identified by 2 experts (1 doctor and 1 pharmacist) based on criteria from the lists STOPP/START and Laroche.

Secondary outcomes

  1. Total number of drugs prescribed per discharge prescription sheet

    Time frame: at discharge (average 3 weeks)

  2. Number of rehospitalization within 12 months following discharge

    Time frame: 12 months after inclusion

  3. Number of emergency admission within 12 months following hospitalization

    Time frame: 12 months after inclusion

  4. Mortality within 12 months after hospitalization

    Time frame: 12 months after inclusion

Sponsors and collaborators

Lead sponsor

Hospices Civils de Lyon

Other

Registry information

Official study title

OPMED STUDY: Multidisciplinary Program "Optimization of Drug Prescription" : Impact on the Quality of Drug Prescription in Hospitalized Elderly Patients

Acronym: OPMED

Important dates

Study start
2013
Primary completion
2017
Study completion
2017
First posted
Sep 20, 2013
Registry last updated
Sep 28, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.